Navigation Links
Amicus Therapeutics Announces Third Quarter 2009 Financial Results and Strategic Business Updates
Date:10/29/2009

--- --- --- --- --- Total operating expenses 12,953 18,387 39,701 55,174 246,287 ------ ------ ------ ------ ------- Loss from operations (9,300) (13,474) (29,079) (40,292) (214,655) Other income (expenses): Interest income 1,019 129 4,053 924 13,684 Interest expense (49) (84) (179) (155) (1,802) Change in fair value of warrant liability - - - - (454) Other expense - - - - (1,180) --- --- --- --- ----- Loss before tax benefit (8,330) (13,429) (25,205) (39,523) (204,407) Benefit from income taxes 150 - - - 695 --- --- --- --- --- Net loss (8,180) (13,429) (25,205) (39,523) (203,712) Deemed dividend - - - - (19,424) Preferred stock accretion - - - - (802) --- --- --- --- --- Net loss attributable to common stockholders $(8,180) $(13,429) $(25,205) $(39,523) $(223,938) ======= ======== ======== ======== ========= Net loss attributable to common stockholders per common share - basic and diluted $(0.36) $(0.59) $(1.12) $(1.75) ====== ====== ====== ====== Weighted-average common shares outstanding - basic and diluted 22,517,431 22,621,513 22,465,981 22,617,808 ========== ========== ========== ========== Table 2
'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Cambridge Semantics, the leading provider of smart data solutions driven ... record-breaking year across the board for the company. , ... and our Smart Data solutions, our customers were able to ... to record growth for the company in 2014,” said Alok ...
(Date:1/22/2015)... CO / Rootstown, OH (PRWEB) January 22, 2015 ... detection platform, announced today that it has received AOAC-PTM Certifications ... O45, O1O3, O111, O121, and O145; collectively referred to as ... coli) O157, at 1 colony forming unit (cfu) per 325 ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was ... Pre-Conference seminar on probiotics in San Diego, CA. , ... conference for health care professionals. This year’s pre-conference seminar was ... in health. Dr. Leyer spoke about the emerging topics and ...
(Date:1/22/2015)... NJ (PRWEB) January 22, 2015 ... technologies such as the Bioruptor® and complete solutions ... system for chromatin immunoprecipitation, alleviating the need for ... and controls needed for ChIP of histones or ...
Breaking Biology Technology:Cambridge Semantics Announces Record Results for 2014 2Crystal Diagnostics Awarded AOAC-PTM Accreditation for the Rapid Detection of “Big 6” E.coli Food Pathogens 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... is opening a liason office with one or two ... Tanaka, vice president and general manager of NTT Energy ... opportunities for the company to expand further in the ... governor Jim Doyle's trade mission to Japan in September ...
... that she would like Wisconsin to double the amount of ... program. , ,In an interview, Burke said funding increases would ... like to double the tax credits from the $3 million ... had bipartisan support, the state made available $65 million in ...
... Wis. Small Tree Communications said it ... Chippewa Valley Angel Investing Network , which invested $445,000 in ... drivers and other products for Apple's Mac OS X. It ... million in funding has been allocated for the company to ...
Cached Biology Technology:Burke would like to double Act 255 angel tax credits 2
(Date:12/15/2014)... Dec. 12, 2014 Research and Markets ( ... "Global Facial Recognition Market 2015-2019" report to their ... Facial recognition is a technology used for the ... facial feature of a person such as nose, jaw ...
(Date:12/11/2014)... , Dec. 10, 2014  That blood pressure plays a role ... Hypertension – the medical term for high blood pressure – ... and the inflatable cuff that,s used in measuring blood pressure ... there,s nothing new about hypertension, its triggers and its effects. ...
(Date:12/10/2014)... a leader in performance biometric data sensor technology, today ... licensees for highly accurate, clinically validated biometric technology. This ... fitness and health sectors, but first responders/military and gaming ... as useful as the biometric data it delivers. As ...
Breaking Biology News(10 mins):Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 2Global Facial Recognition Market 2015-2019: Key Vendors are 3M Cogent, Cognitec Systems, NEC and Safran Group 3Research points to need for new approaches to treatment of high blood pressure 2Research points to need for new approaches to treatment of high blood pressure 3Research points to need for new approaches to treatment of high blood pressure 4Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... predatory garter snakes and their newt quarry is turning ... molecular level, another battle rages. And in this second, ... Biologists at Indiana University Bloomington, Utah State University and ... Nature that a toxin produced by the rough skinned ...
... clouds could play a crucial role in the spread ... scientists have claimed. , The radical theories about nanobacteria ... are published in two recent articles in the Journal ... the University of Ulm, Germany, and Professor Chandra Wickramasinghe ...
... School of Medicine in St. Louis have learned that ... earlier successes in treating diabetic rats with embryonic pig ... were surprised to find that they didn't have to ... pig cell transplants. They had expected rats that received ...
Cached Biology News:At the molecular level, the predator is the prey 2At the molecular level, the predator is the prey 3Nanobacteria in clouds could spread disease, scientists claim 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 2Precise Timing Enabled Pig-to-rat Transplants To Cure Diabetes 3
An excellent carbonyl-reactive FRET quencher paired with Trp or Tyr. Minimum Purity: 95%. Abs(max): ~350 nm; Em(max): none. Solvent System:DMSO or DMF....
EDG-6 (1)...
Complexin-1/2 (FL-134)...
... Comments: Ab-1 stains tumor cells ... not other type of germ cell tumors like ... immature teratoma are positive. Luminal and endocrine cells ... lobules of breast are also positive. ...
Biology Products: